Cataract surgery performed by phacoemulsification is an elegant surgery, but recent advances in technology offer the potential to further enhance the cataract surgery experience for patients and ...
VVN461, a non-steroidal dual JAK1/TYK2 immunomodulator, achieves primary endpoint, demonstrating statistical and clinical efficacy compared to vehicle in treating post-operative inflammation following ...